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Summary 
While a number of growth factors have been described 
that are highly specific for particular cell lineages, nei- 
ther a factor nor a receptor uniquely specific to the 
skeletal muscle lineage has previously been de- 
scribed. Here we identify a receptor tyrosine kinase 
(RTK) specific to skeletal muscle, which we term 
"MUSK" for muscle-specific kinase. MuSK is expressed 
at low levels in proliferating myoblasts and is induced 
upon differentiation and fusion. In the embryo, it is 
specifically expressed in early myotomes and devel- 
oping muscle. MuSK is then dramatically down- 
regulated in mature muscle, where it remains promi- 
nent only at the neuromuscular junction; MuSK is thus 
the only known RTK that localizes to the neuromuscu- 
lar junction. Strikingly, MuSK expression is dramati- 
cally induced throughout the adult myofiber after de- 
nervation, block of electrical activity, or physical 
immobilization. In humans, MuSK maps to chromo- 
some 9q31.3-32, which overlaps with the region re- 
ported to contain the Fukuyama muscular dystrophy 
mutation. Identification of MuSK introduces a novel 
receptor-factor system that seems sure to play an im- 
portant and selective role in many aspects of skeletal 
muscle development and function. 
Introduction 
Growth factors produced by one cell and recognized by 
cell surface receptors on other cells provide for a major 
mode of intercellular communication. Specificity in this 
type of communication often depends upon the distribu- 
tion of receptors for a given growth factor, which deter- 
mines the cells that can respond to the factor. Some fac- 
tors, such as insulin and its relatives, have broadly 
expressed receptors and thus simultaneously signal to, 
and elicit responses from, most cells in the body (Lee and 
Pilch, 1994). Other factors have receptors that are quite 
specific for particular cell types, allowing responses only 
by selected cellular targets. Examples of such factors in- 
clude members of the nerve growth factor family, each of 
which acts on particular subpopulations of neurons and 
only at discrete stages of their development (Barbacid, 
1993; Glass and Yancopoulos, 1993; Snider, 1994). There 
are several receptors that are exclusively expressed on 
endothelial cells and that allow for the lineage-specific ac- 
tions of factors such as vascular endothelial cell growth 
factor (Fong et al., 1995; Sato et al., 1995). Similarly, many 
hemopoietic lineages can be specifically regulated by cy- 
tokines, such as erythropoietin and thrombopoietin, that 
act only on these lineages (Miyajima et al., 1992). While 
a number of generally acting growth factors have been 
shown to act on cells of the skeletal muscle cell lineage, 
neither a factor nor a receptor uniquely specific to this 
lineage has thus far been described. One could imagine 
that such a factor and its receptor, if they were to exist, 
might mediate critical aspects of skeletal muscle develop- 
ment, might somehow regulate muscle metabolism or 
function, might be involved in muscle maintenance, and 
could be therapeutically useful for muscle responses to 
stress and injury without affecting other cell systems. 
Skeletal muscle is derived from mesodermal structures 
in the embryo that are termed somites (reviewed in 
Hauschka, 1994). By a process that is not completely un- 
derstood, but that apparently involves myogenic determi- 
nation transcription factors (MDFs) such as myf5, myo- 
genin, and myoD, proliferating cells in the dorsal region 
of the somite become committed to the muscle lineage 
(reviewed in Li and Olson, 1992; Hauschka, 1994). Some 
of these myoblasts exit the cell cycle and m igrate ventrally 
to form the myotomal region of the somite, from which 
axial muscles are derived. Other rnyoblasts migrate out 
from the lateral portion of each somite and instead form 
body wall and limb muscles. Myoblasts that exit the cell 
cycle begin to differentiate, start to express muscle- 
specific structural proteins, and eventually fuse to form 
multinucleated myotubes. Muscle development involves 
two waves of myotube formation: small numbers of pri- 
mary myotubes seem initially to align fibers for individual 
muscles, and secondary myotubes are subsequently re- 
cruited to build upon this initial scaffold (Kelly and Zacks, 
1969; Ontell and Kozeka, 1984). While the number of pri- 
mary myotubes formed seems to be genetically deter- 
mined, survival of these myotubes apparently depends 
upon functional innervation, and this survival in turn influ- 
ences secondary myotube formation (Ashby et al., 1993a, 
1993b). 
Neuron 
574 
Muscle innervation depends upon formation of a highly 
specialized synaptic connection, termed the neuromuscu- 
lar junction (NMJ), between the incoming nerve and the 
muscle fiber (reviewed in McMahan, 1990; Burden, 1993; 
Hall and Sanes, 1993; Failon and Hall, 1994). Before in- 
nervation, the entire surface of the multinucleated myo- 
fiber contains molecules, such as subunits of the acetyl- 
choline receptor (AChR; (~, 13, 8, and ~, subunits), that will 
later be highly localized to the N MJ. Localized aggregation 
at the endplate is apparently induced by secretion, from 
the motor nerve terminal, of a protein termed agrin (McMa- 
han, 1990; Fallon and Hall, 1994). In addition to initiating 
agrin-mediated aggregation of preexisting AChR, innerva- 
tion has dramatic effects on muscle gene expression (Bur- 
den, 1993). For example, onset of electrical activity sup- 
presses expression of AChR (~, 13, (5, and 7 mRNAs by all 
extrajunctional nuclei, while a neural factor released by 
the nerve terminal (perhaps corresponding to a member 
of the neuregulin family) promotes continued expression 
of (x, 13, and (5 transcripts only by the subsynaptic nuclei 
and also seems to turn on expression of AChR ~ mRNA 
in these nuclei (Burden, 1993; Falls et al., 1993; Jo et 
al., 1995). Developing myofibers are initially innervated 
by multiple axons that terminate at a single synaptic site. 
Subsequently, synapses are eliminated, leaving each my- 
ofiber innervated by a single axon and refractory to receiv- 
ing additional innervation (Hall and Sanes, 1993). Dener- 
vation or other inhibitors of electrical activity, even in an 
adult muscle, will result in rapid and dramatic up- 
regulation of (~, 13, (5, and y mRNAs in extrajunctional nuclei 
in a fiber-wide pattern and will release the block on multiply 
innervating fibers (Burden, 1993; Hall and Sanes, 1993); 
thus, in many ways, denervation may resemble regression 
to a more embryonic state. Furthermore, mononucleated 
myogenic precursors that are intimately associated with 
myofibers but are quiescent in adult muscle, known as 
satellite cells, can be reactivated by denervation; satellite 
cells can also be activated in response to direct muscle 
trauma or in dystrophies (reviewed in Bischoff, 1994). De- 
nervation or loss of muscle activity due to other pathologi- 
cal conditions has dire consequences for the muscle. A 
sharp drop in muscle protein synthesis and a rise in protein 
degradation lead to rapid muscle atrophy, reducing total 
muscle mass by 80% in the first 3 weeks following dener- 
vation (Engel and Stinnington, 1974). The effects of dener- 
vation are thought to be due to both interruption of electri- 
cal activity, which itself seems to have trophic effects upon 
muscle, as well as loss of muscle-sustaining factors 
(termed "myotrophic" factors) released by the nerve termi- 
nal (reviewed in Grinnel, 1994). 
Growth factors have already been suggested to play 
important roles in many aspects of muscle development 
and function (reviewed in Olson, 1992; Hauschka, 1994). 
Fibroblast growth factors (FGFs) and transforming rowth 
factor 13s (TGFI3s) may be important for mesoderm induc- 
tion, which is required for subsequent muscle formation. 
The neural tube or notochord, and perhaps other embry- 
onic structures, are thought to release factors that may 
induce muscle differentiation in the somite. Myoblast pro- 
liferation, in vitro, depends on serum that can be replaced 
to varying degrees by a variety of growth factors such 
as FGFs, TGFI3s, platelet-derived growth factor (PDGF), 
epidermal growth factor (EGF), the insulin-like growth fac- 
tors (IGFs), and leukemia inhibitory factor (LIF); some of 
these factors also regulate differentiation and fusion, with 
TGFI3s apparently blocking differentiation and IGFs pro- 
moting differentiation. It is unclear what role, if any, these 
factors play in regulating myoblast proliferation in vivo. It 
has been suggested that serum and growth factors main- 
tain in vitro myoblast proliferation and prevent terminal 
differentiation by inactivating MDFs via phosphorylation 
cascades; interestingly, terminal differentiation correlates 
with down-regulation of many of these growth factor recep- 
tors. Factors released by the nerve terminal, such as the 
neuregulins, may be involved in regulating transcription 
from synaptic nuclei (Burden, 1993; Falls et al., 1993; Jo et 
al., 1995). Other factors found in peripheral nerve extracts, 
and IGFs and ciliary neurotrophic factor (CNTF) in particu- 
lar (Grinnel, 1994; Helgren et al., 1994), may have myo- 
trophic actions that reduce muscle'wasting following de- 
nervation. 
None of the aforementioned growth factors, however, 
acts solely on muscle lineage cells. Because other cell 
types utilize lineage-specific growth factors, and because 
identification of such a growth factor specific to skeletal 
muscle seems sure to have important consequences, we 
set out to obtain evidence for such a factor. Toward this 
end, we chose to determine whether we could identify a 
novel growth factor receptor specific to the skeletal muscle 
lineage. We focused on identifying a muscle-specific 
member of the receptor tyrosine kinase (RTK) superfamily 
(Schlessinger and UIIrich, 1992) because cDNAs encod- 
ing members of this superfamily can be molecularly cloned 
via approaches that exploit sequence similarities within 
the catalytic kinase domains of these receptors (e.g., 
Wilks, 1989; Lai and Lemke, 1991). We searched for RTKs 
expressed in denervated skeletal muscle, based on the 
notion that denervation may induce reexpression of em- 
bryonically important RTKs; denervation might also up- 
regulate RTKs that might be involved in NMJ plasticity, 
in other responses dependent on muscle activity, or in 
muscle atrophy. This search resulted in the identification 
of a RTK we term "MUSK" for muscle-specific kinase. 
MuSK is expressed at low levels in proliferating myoblasts, 
is induced by differentiation and fusion, and is expressed 
in the developing myotomes of the embryo. MuSK remains 
highly expressed during muscle development and then 
becomes dramatically down-regulated in mature muscle, 
where it remains prominent only at the NMJ. Thus, MuSK 
appears to be involved in early muscle development and 
may also be important for function of the NMJ in the adult. 
Strikingly, MuSK expression is reinduced throughout he 
myofiber following denervation, block of electrical activity, 
and physical immobilization, suggesting additional roles 
for MuSK in the response to injury, atrophy, or changes 
in muscle activity. In addition, the MuSK gene maps to 
mouse chromosome 4 and its syntenic counterpart at hu- 
man chromosome 9q31.3-32, which overlaps with the re- 
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gion reported to contain the Fukuyama muscular dystro- 
phy mutation, raising the possibility that loss of MuSK 
function may account for this disorder. 
The closest known relative of MuSK is a receptor cloned 
from the electric organ of the electric ray Torpedo califor- 
nica, which was also found to be specifically expressed 
in the skeletal muscle of this organism (Jennings et al., 
1993); because the electric organ is a specialized variant 
of skeletal muscle, MuSK and its orthologs appear to have 
crucial muscle lineage-restricted functions that are con- 
served across long evolutionary distances. Identification 
of MuSK and description of its restricted expression profile 
introduce a novel receptor-factor system that seems sure 
to play an important role in many aspects of skeletal mus- 
cle development and function. 
Results 
Molecular Cloning of MuSK from Denervated 
Skeletal Muscle 
Based on the notion that denervation might result in reex- 
pression of embryonically important muscle proteins, or 
induction of proteins involved in responses to injury or 
changes in muscle activity, we attempted to isolate cDNAs 
encoding RTKs expressed in denervated muscle. The 
polymerase chain reaction (PC R) was used in combination 
with oligonucleotides corresponding to two conserved re- 
gions (the DLAARN and DVWSYG motifs) found in most 
tyrosine kinase domains to amplify cDNA fragments from 
denervated muscle cDNA encoding portions of tyrosine 
A 
Skel. Muscle 
kinases spanned by the conserved residues. A library of 
these cDNA fragments was constructed and screened to 
remove known kinases (see Experimental Procedures), 
leading to the identification of a novel candidate RTK. 
Probes specific for this candidate RTK were then hybrid- 
ized to Northern blots containing RNA from several adult 
tissue sources, including normal adult skeletal muscle as 
well as denervated skeletal muscle. This Northern analysis 
revealed a very restricted expression pattern in adult tis- 
sues, with prominent expression ly in denervated skele- 
tal muscle (Figure 1A); very low levels of expression were 
also noted in innervated skeletal muscle, as well as in a 
limited number of other tissues including spleen and ret- 
ina. The candidate RTK was thus designated MuSK for 
muscle-specific kinase and subjected to further detailed 
analysis as described below. 
Structural Features of MuSK and Relationship to 
Torpedo RTK and the RORs 
Longer cDNA clones encoding the entire coding region 
of MuSK were cloned from a denervated rat cDNA library 
and from human myoblast cDNA (see Experimental Proce- 
dures). The rat and human versions of MuSK exhibit all 
the canonical features of conventional RTKs--including 
a signal peptide, a large ectodomain, a transmembrane 
region, and a cytoplasmic domain containing the 12 sub- 
domains that characterize a functional tyrosine kinase-- 
and are highly homologous to each other (94% overall 
identity, with 91% identity in their ectodomains and trans- 
membrane regions [45 differences in a total of 515 resi- 
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Figure 1. Northern Blot Analysis of MuSK Ex- 
pression 
Blots show detection of MuSK expression in 
adult rat tissue (A) and during early postnatal 
development ofthe rat gastrocnemius muscle 
(B) or brain (C). Arrows indicate the -7.0 and 
-3.5 kb MuSK-specific transcripts. N and D, 
naive and denervated extensor digitorus Ion- 
gus (EDL) and gastrocnemius skeletal muscle, 
respectively; Oil, olfactory bulb; Ctx, cortex; 
Hip, hippocampus; Dien, diecephalon; MBr, 
midbrain; HBr, hindbrain; Cbm, cerebellum; Sp 
Cd, spinal cord; Ret, retina; Thy, thymus; Kid, 
kidney. 
C 
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Figure 2. Sequence, Structural Comparisons, and Chromosomal Mapping of MuSK 
(A) Comparison of human and rat MuSK amino acid sequence to that of Torpedo californica RTK (t-RTK). Only differences from the human MuSK 
sequence are indicated, with periods denoting identity to the human MuSK sequence, and hyphens denoting missing residues. The signal peptide, 
Ig-like domains, C6 box, Kringle domain, transmembrane domain, and conserved subdomains I-XI of the kinase region are indicated; conserved 
residues in the kinase subdomains are in boldface. 
(B) Schematic representation of MuSK structure in comparison to that of Torpedo californica RTK and the Trks. Ig-like domains, the C6 Box, 
Kringle domains, kinase domains, and positions of MuSK insertions are indicated; the ROR kinase domain is differentially striped to indicate that 
it is more distant from the others. 
(C) Cladogram comparing the evolutionary relationships between the indicated RTKs (h-INSR, human insulin receptor). 
(D) Mapping of Musk to mouse chromosome 4 by interspecific backcross analysis as described in the text. A partial chromosome 4 linkage map 
showing the location of Musk in relation to linked genes is shown on the right. The ratios of the total number of mice exhibiting recombinant 
chromosomes to the total number of mice analyzed for each pair of loci and the recombination frequencies between loci expressed in centimorgans 
( _+ SEM) are indicated to the left of the chromosome map. Gene order was determined by minimizing the number of recombination events required 
to explain the allele distribution pattern. Positions of the depicted linked loci in human chromosomes are shown to the right. References for the 
map positions of most human loci can be obtained from the Genome Data Base, a computerized atabase of human linkage information maintained 
by The William H. Welsh Medical Library of The Johns Hopkins University (Baltimore, MD). 
(E) In situ hybridization of a biotin-labeled MuSK probe to metaphase cells from phytohemagglutinimstimulated p ripheral blood lymphocytes. The 
chromosome 9 homologs are identified with arrows; specific labeling was observed at 9q32. The insert shows partial karyotypes of two chromosome 
9 homologs illustrating specific labeling at 9q31.3-32 (arrow). Images were obtained using a Zeiss Axiophot microscope coupled to a cooled CCD 
camera. Separate images of DAPI-stained chromosomes and the hybridization signal were merged using image analysis software (NU200 and 
Image 1.52b). 
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dues] and 97% identity in their intracellular domains [11 
differences in a total of 358 residues]; Figure 2A). Several 
distinct cDNAs were isolated encoding slightly different 
versions of human MuSK that differ by the presence of 
either I or 2 different insertions (a 10 amino acid insertion 
and a 9 amino acid insertion) in the ectodomain (Figures 
2A and 2B). Determination of the structure of the MuSK 
gene reveals that these insertions result from alternative 
splicing that either includes or excludes small exons en- 
coding the insertions (unpublished ata); the splicing that 
results in inclusion of the small exon encoding the 9 amino 
acid insertion removes an alanine residue at the splicing 
junction (Figure 2A). 
The ectodomains of rat and human MuSK can be subdi- 
vided into four immunoglobulin-like (Ig-like) domains, with 
the third and fourth Ig-like domains separated by a rather 
large spacer containing 6 conserved cysteines (Figures 2A 
and 2B, C6 box). Among all known RTKs, rat and human 
MuSK are most highly related to a RTK previously cloned 
from the electric organ of the electric ray Torpedo califor- 
nica (Jennings et al., 1993). The Torpedo RTK contains 
all the major features of the rat and human MuSK proteins, 
but in addition includes a Kringle domain just after the 
fourth Ig-like domain (Figures 2A and 2B). Analysis of mul- 
tiple MuSK transcripts as well as the MuSK gene indicates 
that Kringle-containing isoforms of MuSK do not exist (un- 
published data). Torpedo RTK was found to be specifically 
expressed in the electric organ of the electric ray, which 
represents a specialized form of skeletal muscle, as well 
as in skeletal muscle of the electric ray (Jennings et al., 
1993). The related tissue distributions of MuSK and Tor- 
pedo RTK, together with the high homology between these 
evolutionarily distant species (mammalian MuSK and Tor- 
pedo RTK display an overall amino acid identity of - 70%, 
including 61% identity between the ectodomains and 78% 
identity between the cytoplasmic domains), suggest that 
they may represent distant orthoiogs that have retained 
particular importance for the skeletal muscle lineage. 
MuSK and Torpedo RTK display significant homology 
in their ectodomains to another family of receptor-like tyro- 
sine kinases, comprised by ROR1 and ROR2 (Masiakow- 
ski and Carroll, 1992). While the RORs contain only three 
Ig-like domains, the position of these domains, as well as 
conservation of the characteristic C6 spacer box in the 
RORs, is remarkably reminiscent of both MuSK and Tor- 
pedo RTK (Figure 2B), even though the RORs are mark- 
edly less related to MuSK and Torpedo RTK within these 
regions ( -  30% amino acid identity) than MuSK and Tor- 
pedo RTK are to each other; interestingly, the RORs, like 
Torpedo RTK, contain Kringle domains. Thus, the RORs 
appear to be distant relatives of MuSK and Torpedo RTK, 
and the homology in their ectodomains uggests that they 
might recognize structurally related ligands. 
Although the ectodomains of MuSK and Torpedo RTK 
are most related to the RORs, the kinase domains of MuSK 
and Torpedo RTK are most similar to the kinase domains 
of the Trks (Figures 2B and 2C), which serve as receptors 
for the neurotrophins and which mediate neuronal survival 
and differentiative responses (Barbacid, 1993; Glass and 
Yancopoulos, 1993; Snider, 1994). 
MuSK Is Expressed in Early Embryonic Myotomes 
and Subsequently during Embryonic 
Muscle Development 
To determine whether MuSK is expressed prominently in 
early stages of muscle differentiation, we first probed 
Northern blots containing RNA isolated from skeletal mus- 
cles of young rats. MuSK was prominently expressed in 
skeletal muscle of newborns and was rapidly down- 
regulated shortly after birth (see Figure 1 B); early develop- 
mental expression of MuSK was not noted in other tissues 
examined (e.g., brain; see Figure 1C). The finding that 
MuSKwas specifically and prominently expressed in new- 
born muscle inspired an attempt o use in situ hybridization 
techniques to characterize further the temporal and spatial 
patterns of MuSK expression during embryonic develop- 
ment. A developmental study of rat embryos revealed that 
MuSK transcripts could not be detected during early so- 
mite formation prior to myotome differentiation (i.e., prior 
to embryonic day 11 [E l l ]  in the rat, which corresponds 
to E9.5 in the mouse). However, MuSK expression was 
specifically noted in the developing myotomes of the rat 
at the time of their formation at E11 (Figure 3, top panels); 
expression was specific to the myotomes and not noted in 
the overlying dermatomes (Figure 3; and data not shown). 
Comparison of MuSK transcript distribution with that of 
one of the earliest markers of skeletal muscle progenitors, 
R-cardiac actin, revealed striking colocalization at E11, 
except that MuSK was not expressed in cardiac muscle 
as was R-cardiac actin (Figure 3). During further embryonic 
development, MuSK and R-cardiac actin continued to dis- 
play striking colocalization outside of the heart, indicating 
that MuSK is not only expressed at the earliest stages of 
myotome development but also during myotube fusion 
and all later stages of embryonic muscle formation (Figure 
3). Based on the Northern analysis discussed above, 
MuSK expression appears to stay high in developing skel- 
etal muscle until shortly after birth, when its expression 
drops to low levels. 
MuSK mRNA and Protein Induced by Denervation 
as well as Disuse in All Muscles Tested 
To determine whether MuSK protein is as dramatically 
induced by denervation as is MuSK mRNA, we generated 
MuSK-specific antisera to immunoblot muscle extracts for 
MuSK protein. No MuSK protein could be detected from 
normal adult muscles, but high levels of a protein of - 100 
kDa could be detected from denervated adult skeletal 
muscle (Figure 4); the same protein was detected by differ- 
ent antisera generated against different epitopes of MUSK, 
and detection could be specifically blocked using peptides 
used to generate the different antisera (data not shown). 
Marked MuSK protein induction occurred in three different 
types of denervated adult muscle: soleus, which is primar- 
ily composed of stow-twitch fibers; extensor digitalis Ion- 
gus (EDL), which is primarily composed of fast-twitch fi- 
bers; and gastrocnemius, which is a mixed fiber muscle 
(Figure 4A). MuSK protein induction was apparent by 2 
days after denervation and reached maximum levels by 
2 weeks after the nerve lesion (Figure 4B). In the absence 
of reinnervation, MuSK protein levels remained elevated 
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Figure 3. tn Situ Localization of MuSK Transcripts in Rat Embryos 
Low magnification views of sagittal sections of rat embryos displaying in situ hybridization of an antisense 3~S-labeled riboprobe for MUSK; in situ 
localization of m-cardiac actin transcripts inadjacent sections as well as hematoxylin-stained bright-field views are provided for comparison, Note 
the precise colocalization of the sites of expression of m-cardiac actin and MUSK, except for the complete absence of MuSK in the heart• Embryonic 
day (11-15) is indicated on the left. 
for prolonged periods (up to 28 days), whereas, following 
a nerve crush injury that allowed for reinnervation, MuSK 
protein levels returned to baseline with reinnervation (Fig- 
ure 4B). 
Consistent with the notion that MuSK induction is 
caused by a decrease in muscle activity, physical immobili- 
zation (as a result of ankle joint fixation) resulted in a dra- 
matic induction of both MuSK mRNA and protein levels 
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Figure 5. Colocalization of MuSK and AChR in Adult Skeletal Muscle 
Frozen sections (10 I~m thick) of the rat sternomastoid muscle are 
depicted. Antibodies against MuSK specifically stain neuromuscular 
synapses (bottom), which are simultaneously visualized using tetra- 
methylrhodamine-labeled ~-bungarotoxin, which detects AChRs (top). 
Figure 4. MuSK Induction in Denervation, Immobilization, and My- 
oblast Differentiation 
(A) MuSK protein induction following denervation of different skeletal 
muscles; (B) time course of this induction in gastrocnemius following 
nerve cut or crush; (C) induction of MuSK rn RNA and protein in gastroc- 
nemius by immobilization as well as denervation; (D) induction of
MuSK protein during C2C12 myoblast differentiation. Immunoblots or 
Northern analysis of MuSK protein or mRNA, as indicated; the number 
of days after the nerve lesion or immobilization is indicated. 
in the gastrocnemius (Figure 4C). We also observed in- 
creased MuSK expression in muscle after block of electri- 
cal activity by application of tetrodotoxin to the sciatic 
nerve (data not shown). 
MuSK Is Expressed in Myoblasts and Up-Regulated 
upon Fusion to Myotubes 
To determine the expression profile of MuSK during the 
in vitro differentiation of myoblast cells, we examined lev- 
els of MuSK protein in the immortalized mouse myoblast 
cell line C2C12. MuSK was expressed at low levels in 
C2C12 myoblast cells prior to differentiation and fusion 
and gradually increased to high levels upon fusion induced 
by serum deprivation (Figure 4D). 
MuSK Colocalizes with AChRs at the NMJ in Normal 
Adult Muscle 
To investigate the subcellular localization of MuSK in adult 
skeletal muscle, immunofluorescence microscopy was 
used to compare MuSK distribution with that of the AChR, 
which is known to be confined to the postsynaptic mem- 
brane of the NMJ (Anderson and Cohen, 1974). Frozen 
sections of muscle were double labeled with tetrameth- 
ylrhodamine-conjugated c~-bungarotoxin, which specifi- 
cally labels AChRs, or with antisera specific to MuSK de- 
tected with a fluorescein-conjugated secondary antibody. 
In normal adult muscle, MuSK-specific immunostaining 
was confined to neuromuscular synapses as judged by 
precise colocalization with AChRs (Figure 5, compare up- 
per and lower panels); the MuSK immunostaining was 
blocked by the peptide used to raise the antisera~ MuSK 
immunostaining was not evident in the nonsynaptic mem- 
brane of the myofiber or in the other cell types present in 
skeletal muscle. 
Synaptic localization of AChRs in normal adult muscle 
appears to be due, in part, to the fact that the mRNAs 
encoding the AChR subunits are transcribed only in subsy- 
naptic nuclei; prior to innervation, or following denervation, 
these mRNAs are transcribed by nuclei throughout he 
myofiber. To determine whether the NMJ localization of 
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A. Co-localization of MuSK & AChRSTranscripts in Normal Muscle 
Hematoxylin & Eosin AChR$ MuSK 
B. MuSKTranscripts Induced Throughout Muscle Fibers by Denervation 
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Figure 6. MuSKTranscriptsL•ca•izet•SubsynapticNucleiinN•rma•AdultDiaphragm•whi•eTranscriptsArewidelyExpressedF••••wingDenerva- 
tion of EDL 
In situ hybridizations performed using antisense 35S-labeled riboprobes for MuSK and AChR5 on adjacent sections (A) reveal colocalization of
MuSK and AChR8 transcripts, presumably by subsynaptic nuclei known to express pecifically AChR5 transcripts in normal adult muscle. Bright-field 
view in (A) shows the position of the phrenic nerve, marking the central region of muscle containing abundant NMJs. In (B), comparison of localized 
MuSK expression (presumably by subsynaptic nuclei) in normal muscle (left) contrasts with widespread expression (apparently throughout myofiber, 
as noted by striped pattern overlying longitudinally sectioned myofibers) 4 days following denervation. 
MuSK results from a similar mechanism, in situ hybridiza- 
tions were performed on adjacent sections of normal adult 
diaphragm using probes specific for MuSK or an AChR 
subunit (the 6 chain). Clusters of transcripts for both genes 
were detected only in the central region of the muscle, 
near the nerve, where NMJs are most abundant (Figure 
6A); these clusters were specifically detected by antisense 
and not sense control probes. The finding that these clus- 
ters largely colocalized (Figure 6A) strongly suggests that 
in normal adult muscle the gene for MUSK, like the genes 
for the AChR subunits, is transcribed only by subsynaptic 
nuclei. Following denervation, MuSK transcripts become 
widely detectable throughout he myofibers (Figure 6B), 
indicating abolishment of the restriction of transcription to 
subsynaptic nuclei, as also occurs for AChR transcripts. 
Altogether, the in situ hybridization data coupled with the 
immunolocalization studies provide compelling evidence 
that the subcellular distribution of MuSK closely parallels 
that of the AChR and is perhaps governed by similar mech- 
anisms. That is, MuSK transcr ipts  are widespread through- 
out developing myotubes and early muscle. In mature 
muscle, MuSK becomes highly localized to the NMJ, 
where it remains in normal adult muscle. Following dener- 
vation or other changes in muscle activity, MuSK becomes 
highly and widely expressed throughout he myofiber. 
Thus, these studies indicate that MuSK is the only known 
RTK that localizes to the NMJ, and its localization is dra- 
matically regulated by innervation and muscle activity. 
The MuSK Gene Maps to Mouse Chromosome 4 and 
Human Chromosome 9q31.3-32 
To determine whether the MuSK gene might map near 
any known genetic mutations with phenotypes that might 
be expected to result from MuSK alteration, we determined 
the chromosomal location of the MuSKgene in mouse and 
man. In mice, the location was determined by interspecific 
backcross analysis using progeny derived from mating of 
[(C57BL/6J x Mus spretus) F1 x C57BL/6J] mice. This 
interspecific backcross mapping has been typed for over 
1900 loci that are well distributed among all the autosomes 
as well as the X chromosome (Copeland and Jenkins, 
1991). Genomic DNAs from C57BL/6J and M. spretus 
were digested with several restriction enzymes and ana- 
lyzed by Southern blot hybridization for informative poly- 
morphisms using a rat MuSK cDNA probe, revealing that 
a 14.0 kb M. spretus-specific EcoRI fragment polymor- 
phism could be used to follow segregation of the Musk  
locus in backcross mice. Such an analysis revealed that 
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Musk is located on mouse chromose 4 in a region syntenic 
with human chromosome 9q (see Figure 2D). 
Mapping the MuSK locus in humans confirmed the 
mouse mapping. To localize the human MuSK gene, we 
performed fluorescence in situ hybridization of a biotin- 
labeled genomic MuSK probe to normal human meta- 
phase chromosomes. Hybridization of this probe resulted 
in specific labeling of only chromosome 9 (see Figure 2E). 
Specific labeling of 9q31-32 was observed in four (7 cells), 
three (5 cells), two (10 cell), or one (3 cells) chromatid(s) 
of the chromosome 9 homologs in 25 cells examined. Of 
66 signals observed (66 of 100 21q chromatids from 25 
metaphase cells were labeled), 25 (38%) were located at 
the junction of 9q31.3-32, 36 (54.5%) were located at 
9q32, and 5 (7.5%) were located at the junction of 9q32- 
33.1. Signal was not observed at any other chromosomal 
site. We observed specific signal at 9q32 in a second hy- 
bridization experiment using this probe. These results indi- 
cate that the MuSK gene is localized to chromosome 9 
bands 31.3-32, syntenic to the mouse map position. 
Several interesting mutations map near the position of 
the MuSK gene in both mice and humans. For example, 
vacillans (vc) is a recessive mouse mutation on chromo- 
some 4 that is associated with tremors, swaying of hind- 
quarters, and substantially decreased muscle strength 
(Sirlin, 1956). Fukayama type congenital muscular dystro- 
phy is a human recessive disorder that is the second most 
common type of childhood muscular dystrophy in Japan 
and maps to human chromosome 9q31-33 (Toda et al., 
1993). Further study will be required to determine whether 
either of these diseases can be accounted for by mutations 
in the MuSK gene. 
Discussion 
We report the identification and characterization of rat and 
human versions of a RTK, termed MUSK, that appears to 
be quite specific for the skeletal muscle lineage. MuSK 
appears to be expressed at several critical periods during 
the life of skeletal, but not cardiac, muscle lineage cells. 
Initial embryonic expression of MuSK occurs in the early 
myotome. Expression stays high throughout skeletal mus- 
cle development in the embryo, during myotube fusion 
and subsequent differentiation, wherever skeletal muscle 
is found. Shortly after birth, MuSK expression plummets, 
and MuSK expression in normal adult skeletal muscle ap- 
pears to be highly restricted to the NMJ, as is expression 
of AChRs. Following denervation or loss of muscle activity 
due to immobilization, MuSK expression is up-regulated 
throughout he myofiber and stays high unless reinnerva- 
tion occurs. 
The small number of RTKs that are known to be ex- 
pressed in a lineage-specific manner have all been shown 
to serve critical roles for those lineages (Snider, 1994; 
Fong et al., 1995; Sato et al., 1995). The intriguing expres- 
sion pattern of MuSK is highly suggestive of important 
functions for this receptor and its putative ligand in several 
aspects of skeletal muscle development and function. Ex- 
pression of some MDFs, most notably myf5, which is ap- 
parently expressed in the somite prior to myotome forma- 
tion, appears to precede that of MuSK (Li and Olson, 1992; 
Hauschka, 1994). On the other hand, MuSK expression 
may occur prior to the appearance of late-appearing MDFs 
such as MyoD (Li and Olson, 1992; Hauschka, 1994). Al- 
though a precise side by side analysis of MuSK expression 
compared with the MDFs must be performed, the current 
data would be consistent with the possibility that some of 
the MDFs are involved in initiating MuSK expression, while 
MuSK itself might regulate onset of later MDFs. Although 
most known growth factor receptors, such as those for 
FGFs, PDGF, and EGF, are rapidly down-regulated follow- 
ing cessation of the proliferative phase of myoblast devel- 
opment (Hauschka, 1994), MuSKexpression remains high 
throughout early muscle development in vivo and in- 
creases as myoblasts differentiate during culture in vitro. 
Thus, in contrast to growth factors that primarily seem to 
maintain myoblast proliferation or the earliest phases of 
differentiation, the putative ligand for MuSK may continue 
to serve a critical role during later stages of differentiation. 
In normal adult muscle, expression of MuSK is restricted 
to the NMJ. Thus, MuSK is the first RTK known to be 
expressed in this crucial subcellular location (Falls et al., 
1993; Jo et al., 1995). Expression at the NMJ suggests 
an important signaling role that could be critical for the 
formation, organization, maintenance, or function of this 
highly specialized structure. Thus, MuSK could be in- 
volved in the early stages of agrin-mediated aggregation of 
AChRs; it has been noted that such aggregation involves 
tyrosine phosphorylation of AChRs (Wallace et al., 1991). 
As a growth factor receptor localized to the NMJ, MuSK 
also becomes a prime candidate for mediating the critical 
survival role played by incoming nerves on the primary 
myotube scaffold. MuSK may also be involved in promot- 
ing specific transcription of certain genes (including those 
for AChR subunits as well as MuSK itself) from subsynap- 
tic nuclei, as has been suggested for the neuregulins, 
which appear to be released from nerve terminals and are 
thought o act on receptors at the NMJ (Falls et al., 1993; Jo 
et al., 1995). MuSK may well contribute to other responses 
mediated by the nerve terminal, perhaps due to regulated 
release by the terminal of the putative MuSK ligand. In 
addition to producing agrin, promoting myotube survival, 
and regulating expression at subsynaptic and extrajunc- 
tional nuclei, neural influences are clearly involved in the 
pruning of excess synapses formed early in development, 
in the continued editing of synapses throughout life, in the 
regulation of structural protein synthesis or degradation 
and resulting muscle growth or atrophy, in the determina- 
tion of muscle fiber types, in the production of muscle- 
derived neurotrophic factors, and in an assortment of other 
processes. While some of these neural influences may 
depend in part upon nerve regulation of muscle activity, 
neural influences also appear to involve release of growth 
factors by the nerve terminal. For example, the rapid mus- 
cle atrophy resulting from denervation is thought o be due 
to both interruption of electrical activity, which itself seems 
to have trophic effects upon muscle, as well as loss of 
muscle-sustaining factors (termed "myotrophic" factors) 
released by the nerve terminal (Grinnel, 1994). 
In fact, activity-mediated effects appear to be inextrica- 
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bly linked to changes in growth factors and their receptors. 
Muscle activity appears to regulate muscle-derived neuro- 
trophic factors: denervation or muscle inactivation can 
markedly alter muscle production of such factors, and it 
has recently been shown that exercise and increased mus- 
cle activity lead to increased expression of neurotrophin-4 
(Funakoshi et al., 1995). Denervation can also dramati- 
cally affect expression of growth factor receptors on skele- 
tal muscle, which presumably alters responsivity of skele- 
tal muscle to factors recognizing these receptors. Prior to 
the findings reported here for MUSK, the IGF and CNTF 
receptors represented the only known examples of growth 
factor receptors up-regulated by denervation (Davis et al., 
1993; Grinnel, 1994; Helgren et al., 1994). Interestingly, 
exogenously provided IGF and CNTF both seem capable 
of blunting the muscle atrophy resulting from denervation 
(Grinnel, 1994; Helgren et al., 1994). Parallels with MuSK 
suggest that the ligand for this novel receptor may act 
as a very specifically acting growth factor for denervated 
skeletal muscle. MuSK is also the only known growth 
factor receptor whose expression is dramatically up- 
regulated not only by denervation but by physical immobili- 
zation of muscle as well, raising the possibility that the 
ligand for MuSK may be trophic in this instance as well; no 
other factors are known that may prevent disuse atrophy. 
Since muscle size and strength are normally regulated by 
the daily level of activity and work performed by the mus- 
cle, MuSK may also be involved in nonpathological regula- 
tion of muscle growth. 
The finding that the ectodomain of MuSK resembles 
those of the RORs, while the kinase domain is instead 
similar to those of the Trk neurotrophic factor receptors, 
suggests that RTKs can evolve in a modular fashion. Thus, 
the ectodomain of MuSK may bind to a ligand unrelated to 
the neurotrophins but instead structurally similar to those 
recognized by the RORs, while the cytoplasmic domain 
of MuSK may mediate survival or differentiation responses 
more similar to those mediated by the Trks. The closest 
known relative of MUSK, in both its extracellular and cyto- 
plasmic domains, is the receptor cloned from the electric 
organ of the electric ray Torpedo californica, which was 
also found to be expressed specifically in the skeletal mus- 
cle of this organism. Because the electric organ is a spe- 
cialized variant of skeletal muscle, MuSK and its orthologs 
appear to have crucial skeletal muscle lineage-restricted 
functions that are conserved across long evolutionary dis- 
tances. Further characterization of MuSK and identifica- 
tion of its ligand will help define a novel receptor-factor 
system that seems certain to play important roles in many 
aspects of skeletal muscle development and function. 
Experimental Procedures 
cDNA Library and Cloning 
A cDNA library constructed using mRNA purified from denervated rat 
skeletal muscle (S. Davis, T. Aldrich, and G. D. Y., unpublished ata) 
was used as a template for PCR using degenerate oligonucleotide 
primers corresponding to the amino acid sequences DLAARN 
(5' primer) and DVWSYG (3' primer), which are conserved sequences 
in tyrosine kinases (Hanks and Quinn, 1991). The respective se- 
quences of the 5' (sense) and 3' (antisense) primers were 5'- 
TCTTGACTCGAGA(T,C)(T,C)T(N)GC(N)GC(N)(C,A)G(N)AA-3' and 5'- 
GAATTCGAGCTCCC(A,G)(A,T)A(N)GCCCA(N)AC(A,G)TC-3', where 
N indicates inclusion of all 4 bases at a given position and the tail 
sequences are underlined. The resulting PCR products were sub- 
cloned into the Bluescript (Stratagene, Inc., La Jolla, CA) plasmid, 
and a library of bacteria harboring these subclones was screened with 
probes specific to particular kinases to eliminate known kinases. The 
remaining clones were subjected to high throughput DNA sequencing, 
revealing a single novel RTK-like sequence we have termed MUSK. 
To obtain a full-length MuSK cDNA clone, a cDNA library was prepared 
using mRNA from denervated rat gastrocnemius muscle and the Uni- 
ZAP XR vector kit (Stratagene, Inc., La Jolla, CA). Library screening, 
plaque purification, and subcloning were performed as described (Va- 
lenzuela et al., 1993). To obtain the human MuSK sequence, rat probes 
were first used to isolate genomic phage clones spanning the entire 
human MuSKgene (D, M. V., E. R., and G. D. Y., unpublished ata). 
DNA sequence spanning the initiation and termination codons was 
obtained and used to design exact oligonucleotide primers that al- 
lowed for PCR-based amplification (using the TaKaRa LA PCR kit 
optimized for long-range PCR, from Takara Shuzo Co., LTD, Shiga, 
Japan) of the entire human MuSK cDNA from mRNA prepared from 
human myoblasts (Clonetics, Inc., CA). DNA sequencing was per- 
formed using the AB1373A DNA sequencer and Taq Dyedeoxy Termi- 
nator Cycle Sequencing Kit (Applied Biosystems, Inc., Foster City, 
CA). The human and rat MuSK cDNA sequences are listed under 
GenBank accession number U34985. 
In Situ Hybridization 
A DNA fragment, corresponding to amino acids 710-868 from the rat 
sequence depicted in Figure 2A, was subcloned into the Bluescript 
KS(+) plasmid (Stratagene, Inc., La Jolla, CA) for generating RNA 
probes specific for rat MUSK. The ct-cardiac actin probe was kindly 
provided by M. P. Goldfarb, and the AChR$ probe by S. J. Burden. The 
35S-radiolabeled antisense or sense strand probes were transcribed off 
linearized plasmids and used for in situ hybridization as described 
previously (Valenzuela etal., 1993). 
Immunoprecipitations, Immunoblotting, Immunostainings, 
and Labeled ~-Bungarotoxin Stainings 
Anti-peptide (to the peptides SLSHSDLBTRARVSSP and CSIHRILQ- 
RMCERAEGTVGV) polyclonal antisera were generated in rabbits by 
Research Genetics, Inc. (Huntsville, AL). Immunoprecipitations, immu- 
noblotting, and immunostaining using the rat MuSK-specific antisera 
were performed as previously described (Jo et al., 1995; Stitt et al., 
1995). Side by side comparison of immunostaining on frozen sections 
of rat sternomastoid muscle using tetramethylrhodamine-labeled 
a-bungarotoxin to detect AChRs or anti-MuSK-specific antisera de- 
tected using secondary fluorescein-conjugated antibodies was essen- 
tially performed as described previously (Jo et al., 1995). 
Animal Surgeries 
Nerve cuts and nerve crushes were performed as described previously 
(Helgren et al., 1994). For ankle joint fixation, rats were anesthetized 
with ketamine/xylazine, a 0.1 mg/ml solution of epinephrine was in- 
jected into the right heel, and a longitudinal incision was made over 
this region. A 23 gauge needle was inserted through the calcaneus 
and talus, into the shaft of the tibia. The needle was cut flush, and 
the wound was sutured. All animal use in this study was conducted 
in compliance with approved institutional animal care and use proto- 
cols and according to NIH guidelines (Guide for the Care and Use of 
Laboratory Animals, 1985, NIH publication o. 86-23). 
Interspecific Backcross Mouse Chromosomal Mapping 
Generation of mice used for the mapping, protocols, and strategy have 
been detailed previously (Copeland and Jenkins, 1991 ;Valenzuela et 
al., 1995). The Musk probe, a 540 bp EcoRV-Notl fragment of rat 
cDNA, was labeled with [~-32P]dCTP using a nick translation labeling 
kit (Boehringer Mannheim); washing was done at a final stringency of 
0.4 x SSCP, 0.1% SDS at 65°C. A fragment of - 23 kb was detected 
in EcoRI-digested C57BL/6J DNA, and a fragment of 14.0 kb was 
detected in EcoRI-digested M Spretus DNA. The presence or absence 
of the 14.0 kb EcoRI M. Spretus-specific fragment was followed in 
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backcross mice. A description of the probes and restriction fragment 
length polymorphisms for the loci linked to Musk, including CNTF re- 
ceptor, tenasin c (Tnc, formerly Hxb) has been reported previously 
(Valenzuela et al., 1995). 
Fluorescence In Situ Hybridization to Human Chromosomes 
A 14 kb human MuSK genomic DNA fragment (D. M. V., E. R., and 
G. D. Y., unpublished data) was used as the probe. Fluorescence in 
situ hybridization was performed as described previously (Rowley et 
al., 1990). 
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